These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 444274)

  • 21. Effects of various hypolipidemic drugs on fatty acid composition of liver and serum lipids.
    Maier R; Muller K
    Adv Exp Med Biol; 1975; 63():349-57. PubMed ID: 1199873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antilipidemic properties of cis-7-chloro-3a, 8b-dihydro-3a-methylfuro[3,4-b]benzofuran-3(1H)-one, a tricyclic clofibrate related lactone having a structural resemblance to mevalonolactone.
    Witiak DT; Kuwano E; Feller DR; Baldwin JR; Newman HA; Sankrappa SK
    J Med Chem; 1976 Oct; 19(10):1214-20. PubMed ID: 994152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The spontaneously hyperlipidemic old rat as a model for evaluation of hypolipoproteinemic drugs. Effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins.
    Gustafsson K; Kiessling H
    Z Versuchstierkd; 1982; 24(5-6):262-70. PubMed ID: 7170838
    [No Abstract]   [Full Text] [Related]  

  • 24. [Reduction of serum triglycerides with a combined application of butylbiguanide and clofibrate in animal experiments].
    Beckmann VR
    Arzneimittelforschung; 1975 May; 25(5):775-6. PubMed ID: 1242321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental studies on the hypolipidemic activity of chloridarol.
    Bernini F; Musanti R; Trezzi E; Corsini A; Fumagalli R; Meldolesi J; Catapano AL
    Pharmacol Res Commun; 1983 Feb; 15(2):201-15. PubMed ID: 6844377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative studies on the influence of Provasan, Complamine, Sadamine, A-100 and Clofibrat on the behaviour of some lipid fractions of plasma in experimental animals.
    Sulowska Z
    Mater Med Pol; 1974; 6(2):102-6. PubMed ID: 4431240
    [No Abstract]   [Full Text] [Related]  

  • 28. Clofibrate and nicotinic acid.
    Hoffer A
    Can Med Assoc J; 1972 Sep; 107(6):488 passim. PubMed ID: 5057001
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hypolipidemic activity of glycine and its derivatives].
    Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV
    Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
    Bjornsson TD; Meffin PJ; Swezey S; Blaschke TF
    J Pharmacol Exp Ther; 1979 Sep; 210(3):316-21. PubMed ID: 480183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of hypolipidemic agents. 1. Synthesis and hypolipidemic activities of alkoxycinnamic acid derivatives.
    Watanabe T; Hayashi K; Yoshimatsu S; Sakai K; Takeyama S; Takashima K
    J Med Chem; 1980 Jan; 23(1):50-9. PubMed ID: 7359513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypolipidemic drugs.
    Sirtori C; Fumagalli R; Paoletti R
    Adv Exp Med Biol; 1973; 38():171-98. PubMed ID: 4594063
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of drugs on plasma triglyceride metabolism.
    Nikkila EA
    Adv Exp Med Biol; 1972; 26(0):113-33. PubMed ID: 4606489
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis and pharmacological evaluation of a clofibrate-related tricyclic spirolactone, 5-chloro-4',5-dihydrospiro[benzofuran-2(3H),3'(2'H)-furan]-2'-one.
    Witiak DT; Cavestri RC; Newman HA; Baldwin JR; Sober CL; Feller DR
    J Med Chem; 1978 Dec; 21(12):1198-202. PubMed ID: 722728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of etofibrate, clofibrate and nicotinic acid on the cyclic AMP-protein kinase system in rats.
    Catalán RE; Aragones MD; Martinez AM; Armijo M; Priego JG
    Gen Pharmacol; 1979; 10(6):455-8. PubMed ID: 230120
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hypolipidemic activity of substances structurally close to penphenone in rats and mice].
    Polikarpova LI; Reznik SE; Ryzhenkov VV; Khechinashvili GG; Petrova LA
    Vopr Med Khim; 1978; 24(6):835-9. PubMed ID: 216145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic peroxisome proliferators induce morphologic transformation of Syrian hamster embryo cells, but not peroxisomal beta oxidation.
    Sanner T; Mikalsen SO; Rivedal E
    Prog Clin Biol Res; 1991; 369():77-89. PubMed ID: 1946545
    [No Abstract]   [Full Text] [Related]  

  • 38. Stimulation of anti-aggregatory activity from rat aorta by hypolipidemic drugs.
    Weithmann KU; Granzer E
    Artery; 1980; 8(5):475-81. PubMed ID: 7011266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential hypolipidemic agents. X. Plasma lipid-lowering properties of some aliphatic aminoalcohols.
    Bondesson G; Hedbom C; Magnusson O; Stjernström NE
    Acta Pharm Suec; 1974 Nov; 11(5):417-26. PubMed ID: 4440500
    [No Abstract]   [Full Text] [Related]  

  • 40. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
    Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
    Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.